- Details
- Description
Packaging Size:
120’s
Strength:
140 mg
Composition:
Ibrutinib 140 mg
Treatment:
Anti-cancer medicine used in the treatment of certain blood cancers, as prescribed by a qualified healthcare professional.
Form:
Capsule
Brand:
Brutini
Quantity Unit:
Capsules
Manufacturer:
Ziska Pharmaceuticals Limited
Brutini 140 contains Ibrutinib 140 mg, a targeted anticancer medicine belonging to the Bruton’s tyrosine kinase (BTK) inhibitor class. It is used in the treatment of certain blood cancers, including chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). Brutini 140 works by blocking BTK, a protein involved in the growth and survival of certain cancer cells. It should be used only under the supervision of a qualified healthcare professional.
